     United States Senator   John Thune                                                                  July 31  2008                                                                         Press Releases                                                                   Press Office                                                      Thune unveils new bipartisan  bicameral drug reimportation legislation          January 26th  2005   Washington  D C    To promote safe and affordable prescription drugs  Senator John Thune joined three other freshman senators Wednesday to announce details of a new bipartisan  bicameral drug reimportation bill that was introduced in the U S  Senate and House   The new legislation will give Americans immediate relief from the outrageously high cost of prescription drugs  If passed into law  the bill will legalize individual consumers importation of certain prescription drugs for their personal use     Allowing reimportation will give consumers access to safe and affordable prescription drugs     said Thune  R SD     It  s telling that so many new senators are joining together to promote drug reimportation  We  ve talked to the voters and know reducing prescription drug costs is a top priority  This bill will make prescription drugs more affordable to all Americans      The legislation  S  109  will allow the importation of prescription drugs only if the drugs and the facilities where they are manufactured are federally approved  and will require that imported prescription drugs be packaged and shipped using counterfeit resistant technologies to ensure their safety   The legislation is sponsored by Sen  David Vitter  R LA  and House Sponsor Rep  Gil Gutknecht  R MN   Joining Senator Thune in co sponsoring the legislation are Sens  Ken Salazar  D CO  and Jim DeMint  R SC                                                                                                                                                  SR 493                                                                      